Piotr Zapała

8PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersBiologically active moleculesMedical bacteriologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 25, 2023
Prostate Cancer in Transplant Receivers-A Narrative Review on Oncological Outcomes.

Karolina Hanusz, Piotr Domański, Kacper Strojec

|Feb 25, 2023
The Cannabinoid Ligand Arachidonyl-2'-Chloroethylamide (ACEA) Ameliorates Depressive and Overactive Bladder Symptoms in a Corticosterone-Induced Female Wistar Rat Model.

Łukasz Zapała, Grzegorz Niemczyk, Piotr Zapała

|Sep 09, 2022
The Clinical Utility of Systemic Immune-Inflammation Index Supporting Charlson Comorbidity Index and CAPRA-S Score in Determining Survival after Radical Prostatectomy-A Single Centre Study.

Piotr Zapała, Karolina Garbas, Zbigniew Lewandowski

|May 28, 2022
The Four-Feature Prognostic Models for Cancer-Specific and Overall Survival after Surgery for Localized Clear Cell Renal Cancer: Is There a Place for Inflammatory Markers?

Łukasz Zapała, Aleksander Ślusarczyk, Rafał Wolański

|Dec 10, 2021
E-Cadherin, Integrin Alpha2 (Cd49b), and Transferrin Receptor-1 (Tfr1) Are Promising Immunohistochemical Markers of Selected Adverse Pathological Features in Patients Treated with Radical Prostatectomy.

Piotr Zapała, Łukasz Fus, Zbigniew Lewandowski

|Oct 23, 2021
The Role of Microbial Factors in Prostate Cancer Development-An Up-to-Date Review.

Karolina Garbas, Piotr Zapała, Łukasz Zapała

Pageof 2

Frequent Collaborators

5 joint publications

Łukasz Zapała

2 joint publications

Karolina Garbas

2 joint publications

Aleksander Ślusarczyk

1 joint publications

Bartosz A Dybowski